Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property Routine +

Promino Nutritional Sciences Launches NCAA Division I Athlete Platform Through Multi-Sport NIL Partnership with Virginia Military Institute

“Promino taps NCAA Division I athletes to showcase rapid‑absorption amino‑acid tech”

Executive Summary
  • On 9 Apr 2026 Promino announced a multi‑sport NIL (Name, Image & Likeness) partnership with eight Division I student‑athletes at Virginia Military Institute (VMI).
  • The athletes will receive Promino’s NSF‑Certified for Sport® amino‑acid formulation (“Rejuvenate Muscle Health™”) as part of their training and recovery regimen.
  • CEO Vito Sanzone frames the deal as a “foundational step” to build brand presence in collegiate athletics, with an eye toward scaling the model to additional NCAA programs.
Material Impact
  • Scope: The agreement is limited to eight athletes at a single institution – a pilot rather than a broad commercial rollout.
  • Financial relevance: No immediate revenue or cash‑flow impact disclosed; the partnership is primarily marketing/branding.
  • Expectation vs. reality: Promino has previously signaled intent to leverage NIL platforms for brand exposure. The announcement therefore meets prior expectations and does not constitute a surprise catalyst.
  • Market reaction potential: Given the modest size, the news is unlikely to move the share price materially; it reinforces the company’s growth narrative but adds limited quantitative upside.

Conclusion: The release is positive in tone but routine relative to earlier guidance on pursuing NIL partnerships. It does not alter the fundamental valuation outlook.

MUSL · Price
Company Overview

Promino Nutritional Sciences develops low‑calorie, sugar‑free amino‑acid blends targeting muscle health for consumers using GLP‑1 weight‑loss therapies and athletes seeking rapid protein synthesis. The flagship “Rejuvenate Muscle Health™” line is sold in powder stick packs (≈3.5 M servings produced in March 2026) and has earned the 2025 ECRM “Best Drink” award. An RTD version is planned for Q3 2026.

Read the original news release →

More from Promino Nutritional Sciences Inc